Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 137
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)
Phase IV
G-PCNSL-SG1
NCT00153530
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
Phase III, Phase II
RPCI-I-72806
I 72806, NCT00536601
Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
Phase III
DSHNHL 2006-1B / ACT-2
BMBF GFVT 01014715, NCT00725231
Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase II, Phase I
RTOG-0227
NCT00068250
Rituximab, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
Phase II, Phase I
OHSU-1012
OHSU-SOL-05025-L, NCT00293475
Allogeneic Cytokine-Induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies
Phase II, Phase I
CIK#2/2007
NMRC/1097/2006, NCT00460694
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With T-Cell Diseases
Phase II, Phase I
FDA IND 100712
96-MH-01, NCT00611208
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
Phase II, Phase I
CLBH589B2102
NCT00621244
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
Phase II, Phase I
25223
PSU25223, NCT00626626
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies
Phase II, Phase I
8717
NCT00673114
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute